Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. - Wikidata - awgldk - TriplyDB

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.

http://www.wikidata.org/entity/Q33831448

about

Acute-on-chronic liver failure: a new syndrome in cirrhosis Bacterial infections in cirrhosis: A critical review and practical guidance Reviewing the diagnostic criteria for acute-on-chronic liver failure.Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience.Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure.ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease.Hyponatremia and Hepatorenal Syndrome Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.Population-representative Incidence of Acute-On-Chronic Liver Failure: A Prospective Cross-Sectional Study.The Clinical Course of Cirrhosis Patients Hospitalized for Acute Hepatic Deterioration: A Prospective Bicentric Study.Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.Pattern and profile of chronic liver disease in acute on chronic liver failure.Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure.Cirrhotic Multiorgan Syndrome.Liver transplantation in acute on chronic liver failure: challenges and an algorithm for patient selection and management.Keeping high model for end-stage liver disease score liver transplantation candidates alive.Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.Acute-on-chronic liver failure: terminology, mechanisms and management.Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: a systematic review and meta-analysis.Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 2.Acute on chronic liver failure because of acute hepatic insults: Etiologies, course, extrahepatic organ failure and predictors of mortality.Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism.Acute on Chronic Liver Failure-What is in a 'Definition'?New concepts in acute-on-chronic liver failure: Implications for liver transplantation.Acute-on-chronic liver failure: an update.Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience.Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.Ascites, refractory ascites and hyponatremia in cirrhosis.Time trends in the health care burden and mortality of acute on chronic liver failure in the United States.Pro: Acute-on-chronic liver failure.Infections complicating severe alcoholic hepatitis: Enterococcus species represent the most frequently identified pathogen.Albumin Prevents Infections in Patients with Chronic Liver Failure in a Single-arm Feasibility Trial.Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality.DAMP molecular IL-33 augments monocytic inflammatory storm in hepatitis B-precipitated acute-on-chronic liver failure.CD14+CD15-HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure.The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis.[Acute-on-chronic liver failure: a diagnostic and therapeutic challenge for intensive care].A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis.Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.

P2860

Q26752480-6B36C64F-CD34-44AD-9C77-7D0E25E61A1C Q26766663-D14435A6-5B3C-4CFF-8CDD-137861028C1F Q30243874-1A71EF25-A9BF-450F-80F1-B4ACE15A9453 Q36154078-FEBC3000-1BA4-4638-880C-232C60EEC0F1 Q36341736-3CE95A31-72D6-4CD8-A7AF-6F15366929C5 Q36527179-4E7A08BA-CAD3-4794-8B81-3CD4225A4E20 Q36747818-ECEAE5A8-2761-4BEF-B1B0-4348EC898B76 Q36812531-80D35A8F-D46E-431C-953F-64FE0A48CAF7 Q36870839-4E7F8C49-BDAC-42AB-90D3-945E880D21F8 Q37162349-D0B1F389-BFE5-478E-9476-6E9B3A192B82 Q37328532-1D06F9C0-55D3-4347-BFA9-4CC12C11AA67 Q37411315-614E42A5-F652-4354-BD43-666996D9655B Q38504279-92368A41-ED19-4E57-AEE8-9198ACD582B8 Q38524991-F0405C5A-8335-4123-9A1C-EE0192817D20 Q38538183-A2064A04-3F4D-48AF-8091-FCE98686B165 Q38544472-045C1A1B-C3F9-49E4-9EB4-6031EAF87CE4 Q38579840-54E0309B-6DED-43E9-A414-0572BF5ACDE0 Q38635623-5B2DBF51-4264-46E4-81EC-B03D89B6B55C Q38720387-300AE641-ECD4-43A1-BABC-0B6B0F21BE06 Q38902015-E7F98772-1ABA-4070-B07D-F18576E45048 Q38935716-7D9766FA-ABCD-409E-9B91-6A948276D77C Q38947953-1BD8C88D-51C0-41DA-B995-FB6316448A3A Q38975697-49741F8F-B52F-432C-A78D-59696A2CB4CB Q38982106-D7B824D7-0ABA-40F0-921B-232C54529080 Q38983071-F50A1DEA-7F43-438E-B2EE-7D4F227F0354 Q39039989-44783296-0ACB-49C9-A1EE-3B0D171F49FF Q39063021-31BDA7BB-C3B5-4934-AB8A-4635A69DC428 Q39206078-D7630E1B-8D9A-4590-8472-D184B8A7B09D Q39323841-D9DE62AF-B30A-4340-8322-F1C1A3C5D214 Q39328453-B578BA81-BE5D-486E-A0ED-7FD5DAE421FA Q39422262-12AD6886-E0AE-41EB-9BC1-E5D3A9D22663 Q39900775-0653C405-58E9-4A04-9047-8D8D29BA8B05 Q40045308-F9FD374B-9925-4419-8878-96A43DF525E5 Q40074990-DF89F373-7BC5-42C8-BE3C-118C0578F23D Q40162133-4BE724EF-B92D-4567-8FBE-85CEE1472866 Q40180993-8C6CA5B1-ECDD-4BF6-870C-7A016CA13EAD Q40185640-ED830C51-2C6B-4BD7-B88B-EC812438A98D Q40328569-EB712916-A4D9-4AE8-956B-FE85AF958B13 Q40519953-37CCEBD9-839A-4237-BA98-593224137C44 Q40734458-C02F0146-6F7F-498B-A874-6BABE77B3FD7

P2860

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.

http://www.wikidata.org/entity/Q33831448

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Survival in infection-related ...... y extrahepatic organ failures.

@ast

Survival in infection-related ...... y extrahepatic organ failures.

@en

type

label

Survival in infection-related ...... y extrahepatic organ failures.

@ast

Survival in infection-related ...... y extrahepatic organ failures.

@en

prefLabel

Survival in infection-related ...... y extrahepatic organ failures.

@ast

Survival in infection-related ...... y extrahepatic organ failures.

@en

P1433

Q33831448-3F59BC17-BE11-4AA8-8EF5-C55A4B767F92

P1476

Q33831448-B53A7C64-B586-451E-A075-1587E9060604

P2093

Q33831448-0F2613F0-7605-415A-86C6-069984E2C585

Q33831448-1B436BB2-153F-47F3-A6C0-16C527836960

Q33831448-26C215BE-E2F2-402D-93BA-C95879CF3DB8

Q33831448-3048F477-A351-41EE-B5EF-0E20C8B24956

Q33831448-443ABE35-2863-4A81-BC8D-4FED6BC44FA0

Q33831448-546EC141-B774-45C8-8AE2-DFBCAD9985A6

Q33831448-615BEFEB-A0F3-48FB-89E8-284E55ADC7AF

Q33831448-6FDCFCA8-097C-42C6-83F6-908ED8936B15

Q33831448-96D5E989-1CDD-48F9-9EFE-0F557AF7168B

Q33831448-A08F825E-CF34-4B61-ABAD-C0E57F8CBC86

P2860

Q33831448-027290D4-4F76-480C-BAEF-A40853B7C005

Q33831448-06F0749B-CF0F-4C83-A8E2-870E666A5E73

Q33831448-25710C85-703A-49FB-AC64-B76E9EF1FE57

Q33831448-3DC1CB7F-6387-40A7-B234-D49B7AF30BEB

Q33831448-49099319-855D-41F3-9D93-190889E1B192

Q33831448-4D257425-769E-4D32-91C9-5CB02CF61078

Q33831448-6B04F984-5084-4A12-8E9F-9F132A05C5D3

Q33831448-8B56BD1D-D30D-4517-9832-FDFD0B44C8F0

Q33831448-A6705B5B-474F-4297-A1DD-D7F2FCAFE397

Q33831448-AFA70735-05DC-4792-A0B8-76B3A5C9A15A

P304

Q33831448-CA5BB778-B0A3-4D3E-9117-6DB6FE5ADBDD

P31

Q33831448-CE98B579-5CCC-49AC-AC68-BDEDEE4C848F

P356

Q33831448-B1E73D05-7B1C-4369-B3E4-E760B656AA58

P407

Q33831448-89436F0F-326B-49A0-BEF6-12358EEE8746

P433

Q33831448-756D9D04-9F28-44EC-9FD0-B5A497895A98

P478

Q33831448-45B87579-8CCA-4C3E-9BAD-F0B6D42B5865

P50

Q33831448-244C8831-61FA-47FF-8FF5-CE214FCA458E

P577

Q33831448-B07CB20F-BC42-4019-A89C-9E199F08027E

P698

Q33831448-5DC6CF50-0E20-4C19-AC7D-48BD4AA685D0

P932

Q33831448-97BA0872-92DE-4F17-9A75-6E1397B46A45

P356

P1433

P1476

Survival in infection-related ...... y extrahepatic organ failures.

@en

P2093

Benedict Maliakkal

http://www.w3.org/2001/XMLSchema#string

Florence Wong

http://www.w3.org/2001/XMLSchema#string

Guadalupe Garcia-Tsao

http://www.w3.org/2001/XMLSchema#string

Heather Patton

http://www.w3.org/2001/XMLSchema#string

Jacqueline G O'Leary

http://www.w3.org/2001/XMLSchema#string

Jasmohan S Bajaj

http://www.w3.org/2001/XMLSchema#string

Leroy R Thacker

http://www.w3.org/2001/XMLSchema#string

Michael B Fallon

http://www.w3.org/2001/XMLSchema#string

North American Consortium For The Study Of End-Stage Liver Disease (NACSELD)

http://www.w3.org/2001/XMLSchema#string

Patrick S Kamath

http://www.w3.org/2001/XMLSchema#string

P2860

APACHE II: a severity of disease classification system

Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management.

New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.

Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience

Bacterial infections in end-stage liver disease: current challenges and future directions

Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis.

Bacterial infections, sepsis, and multiorgan failure in cirrhosis.

Factors that predict short-term intensive care unit mortality in patients with cirrhosis.

High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center.

Immune dysfunction and infections in patients with cirrhosis.

P304

250-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.27077

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

K. Rajender Reddy

P577

2014-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24677131

http://www.w3.org/2001/XMLSchema#string

P932

4077926

http://www.w3.org/2001/XMLSchema#string